TREM2 siRNA inhibits cell proliferation of human liver cancer cell lines

International Journal of Clinical and Experimental Pathology

Volumn 9, Issue 4, 2016, Pages 4318-4328

  Zhang, Sui Liang ^a   Chen, Ting Song ^b   Xiao, Ling ^a   Ye, Ying ^a   Xia, Wei ^a   Zhang, Hong ^a  

^a SHANGHAI SEVENTH PEOPLE S HOSPITAL   (China)

^b EASTERN HEPATOBILIARY SURGERY HOSPITAL   (China)

Author keywords

Cell proliferation; In vivo study; Liver cancer; TREM2 siRNA

Indexed keywords

EID: 84969549293     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. On the rise globally, cancer mortality declines in U.S. Cancer Discov 2014; 4: OF7
2. Ahmed I and Lobo DN. Malignant tumours of the liver. Surgery-Oxford International Edition 2009; 27: 30-37
3. Turnbull IR, Gilfillan S, Cella M, Aoshi T, Miller M, Piccio L, Hernandez M, Colonna M. Cutting edge: TREM-2 attenuates macrophage activation. J Immunol 2006; 177: 3520-3524
4. Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S, Hazrati L, Collinge J, Pocock J, Lashley T, Williams J, Lambert JC, Amouyel P, Goate A, Rademakers R, Morgan K, Powell J, St George-Hyslop P, Singleton A, Hardy J; Alzheimer Genetic Analysis Group. TREM2 variants in Alzheimer's disease. N Engl J Med 2013; 368: 117-127
5. Hickman SE and El Khoury J. TREM2 and the neuroimmunology of Alzheimer's disease. Biochem Pharmacol 2014; 88: 495-498
6. Paloneva J, Manninen T, Christman G, Hovanes K, Mandelin J, Adolfsson R, Bianchin M, Bird T, Miranda R, Salmaggi A, Tranebjaerg L, Konttinen Y, Peltonen L. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am J Hum Genet 2002; 71: 656-662
7. Takahashi K, Rochford CD, Neumann H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J Exp Med 2005; 201: 647-657
8. Ho CC, Liao WY, Wang CY, Lu YH, Huang HY, Chen HY, Chan WK, Chen HW, Yang PC. TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer. Am J Respir Crit Care Med 2008; 177: 763-770
9. Sigalov AB. A novel ligand-independent peptide inhibitor of TREM-1 suppresses tumor growth in human lung cancer xenografts and prolongs survival of mice with lipopolysaccharide-induced septic shock. Int Immunopharmacol 2014; 21: 208-219
10. Zhou J, Chai F, Lu G, Hang G, Chen C, Chen X, Shi J. TREM-1 inhibition attenuates inflammation and tumor within the colon. Int Immunopharmacol 2013; 17: 155-161
11. Liao R, Sun TW, Yi Y, Wu H, Li YW, Wang JX, Zhou J, Shi YH, Cheng YF, Qiu SJ, Fan J. Expression of TREM-1 in hepatic stellate cells and prognostic value in hepatitis B-related hepatocellular carcinoma. Cancer Sci 2012; 103: 984-992
12. Li J, Salcedo R, Mivechi NF, Trinchieri G, Horuzsko A. The proinflammatory myeloid cell receptor TREM-1 controls Kupffer cell activation and development of hepatocellular carcinoma. Cancer Res 2012; 72: 3977-3986
13. Neumann H and Takahashi K. Essential role of the microglial triggering receptor expressed on myeloid cells-2 (TREM2) for central nervous tissue immune homeostasis. J Neuroimmunol 2007; 184: 92-99
14. N'Diaye EN, Branda CS, Branda SS, Nevarez L, Colonna M, Lowell C, Hamerman JA, Seaman WE. TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria. J Cell Biol 2009; 184: 215-223
15. Ito H and Hamerman JA. TREM-2, triggering receptor expressed on myeloid cell-2, negatively regulates TLR responses in dendritic cells. Eur J Immunol 2012; 42: 176-185
16. Lavrik IN, Golks A, Krammer PH. Caspases: pharmacological manipulation of cell death. J Clin Invest 2005; 115: 2665-2672
17. Stennicke HR and Salvesen GS. Biochemical characteristics of caspases-3,-6,-7, and-8. J Biol Chem 1997; 272: 25719-25723
18. Weng C, Li Y, Xu D, Shi Y, Tang H. Specific cleavage of Mcl-1 by caspase-3 in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in Jurkat leukemia T cells. J Biol Chem 2005; 280: 10491-10500
19. Shi Y, Chen J, Weng C, Chen R, Zheng Y, Chen Q, Tang H. Identification of the protein-protein contact site and interaction mode of human VDAC1 with Bcl-2 family proteins. Biochem Biophys Res Commun 2003; 305: 989-996
20. Hsu YT, Wolter KG, Youle RJ. Cytosol-tomembrane redistribution of Bax and Bcl-X(L) during apoptosis. Proc Natl Acad Sci U S A 1997; 94: 3668-3672
21. Nechushtan A, Smith CL, Hsu YT, Youle RJ. Conformation of the Bax C-terminus regulates subcellular location and cell death. EMBO J 1999; 18: 2330-2341
22. Moldovan GL, Pfander B, Jentsch S. PCNA, the maestro of the replication fork. Cell 2007; 129: 665-679
23. Shivji KK, Kenny MK, Wood RD. Proliferating cell nuclear antigen is required for DNA excision repair. Cell 1992; 69: 367-374
24. Essers J, Theil AF, Baldeyron C, van Cappellen WA, Houtsmuller AB, Kanaar R, Vermeulen W. Nuclear dynamics of PCNA in DNA replication and repair. Mol Cell Biol 2005; 25: 9350-9359
25. Enserink JM and Kolodner RD. An overview of Cdk1-controlled targets and processes. Cell Div 2010; 5: 1-41
26. Gould KL, Moreno S, Tonks NK, Nurse P. Complementation of the mitotic activator, p80cdc25, by a human protein-tyrosine phosphatase. Science 1990; 250: 1573-1576